SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-002304
Filing Date
2023-11-09
Accepted
2023-11-09 16:30:39
Documents
72
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nwbo-20230930x10q.htm   iXBRL 10-Q 2408515
2 EX-31.1 nwbo-20230930xex31d1.htm EX-31.1 12921
3 EX-32.1 nwbo-20230930xex32d1.htm EX-32.1 9246
  Complete submission text file 0001410578-23-002304.txt   11096867

Data Files

Seq Description Document Type Size
4 EX-101.SCH nwbo-20230930.xsd EX-101.SCH 82558
5 EX-101.CAL nwbo-20230930_cal.xml EX-101.CAL 58008
6 EX-101.DEF nwbo-20230930_def.xml EX-101.DEF 378378
7 EX-101.LAB nwbo-20230930_lab.xml EX-101.LAB 567611
8 EX-101.PRE nwbo-20230930_pre.xml EX-101.PRE 507317
66 EXTRACTED XBRL INSTANCE DOCUMENT nwbo-20230930x10q_htm.xml XML 2219048
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 231393080
SIC: 2834 Pharmaceutical Preparations